Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lina, B. A.R.
Right arrow Articles by Van Kreijl, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lina, B. A.R.
Right arrow Articles by Van Kreijl, C. F.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*D-MANNITOL
*HALOPERIDOL
*PHENACETIN
*RESERPINE
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Evaluation of the Xpa-Deficient Transgenic Mouse Model for Short-Term Carcinogenicity Testing: 9-Month Studies with Haloperidol, Reserpine, Phenacetin, and D-Mannitol

Ben A.R. Lina

TNO Nutrition and Food Research, Zeist, The Netherlands, lina{at}voeding.tno.ul

Ruud A. Woutersen

TNO Nutrition and Food Research, Zeist, The Netherlands

Joost P. Bruijntjes

TNO Nutrition and Food Research, Zeist, The Netherlands

Jan Van Benthem

National Institute of Public Health and the Environment, Bilthoven, The Netherlands

Jolanda A.H. Van Den Berg

National Institute of Public Health and the Environment, Bilthoven, The Netherlands

Johan Monbaliu

Janssen Pharmaceutica N.V., Beerse, Belgium

Bob J.J.M. Thoolen

Solvay Pharmaceuticals B.V., Weesp, The Netherlands

Rudolf B. Beems

National Institute of Public Health and the Environment, Bilthoven, The Netherlands

Coen F. Van Kreijl

National Institute of Public Health and the Environment, Bilthoven, The Netherlands

As part of the international evaluation program coordinated by ILSI/HESI, the potential of DNA repair deficient Xpa-/- mice and the double knockout Xpa-/-.p53+/- mice for short term carcinogenicity assays was evaluated. For comparison also wild-type C57BL/6 mice (WT) were included in these studies. Four test compounds were administered to groups of 15 male and 15 female Xpa-/- mice, Xpa-/-.p53+/- mice and WT mice for 39 weeks. The model compounds investigated were haloperidol, reserpine (nongenotoxic rodent carcinogens, putative human noncarcinogens), phenacetin (genotoxic rodent carcinogen, suspected human carcinogen), and D-mannitol (noncarcinogen in rodents and humans). The test compounds were administered as admixture to rodent diet at levels up to 25 mg/kg diet for haloperidol, 7.5 mg/kg diet for reserpine, 0.75% for phenacetin, and 10% for D-mannitol. These levels included the maximum tolerable dose (MTD). Survival was not affected with any of the test compounds. Haloperidol, reserpine and D-mannitol were negative in the carcinogenicity assay with Xpa-/- and Xpa-/- .p53+/- mice, showing low and comparable tumor incidences in controls and high-dose animals. The results obtained with phenacetin may be designated equivocal in Xpa-/- .p53+/- mice, based on the occurrence of a single rare tumor in the target organ (kidney) accompanied by a low incidence of hyperplastic renal lesions and a high incidence of karyomegaly. These results are in agreement with the currently known carcinogenic potential of the 4 test compounds in humans.

Key Words: Xpa • Xpa/p53 • knockout mice • carcinogens • carcinogenicity testing • DNA repair deficient.

References

  • Bahneman, R., Jacobs, M., Karbe, E., Kaufmann, W., Morawietz, G., and Nolte, T. (1995). RITA registry of industrial toxicology animal-data-guides for organ sampling and trimming procedures in rats. Exp Toxicol Pathol 47, 247—66.[Medline] [Order article via Infotrieve]
  • Berg, R.J.W., de Vries, A., Van Steeg, H., and De Gruijl, F.R. (1997). Relative susceptibilities of Xpa knockout mice, and their heterozygous, and wild-type littermates to UVB-induced skin cancer. Cancer Res 57, 581—4.[Abstract/Free Full Text]
  • de Vries, A., Van Oostrum, C. Th. M., Dortant, P.M., Beems, R.B., Van Kreijl, C.F., Capel, P.J.A., and Van Steeg, H. (1997). Spontaneous liver tumours and benzo[a]pyrene-induced lymphomas in Xpa deficient mice. Molec Carcinogen 19, 46—53.[CrossRef]
  • de Vries, A., Van Oostrum, C. Th. M., Hofhuis, F.M.A., Dortant, P.M., Berg, R.J.W., De Gruijl, F.R., Wester, P.W., Van Kreijl, C.F., Capel, P.J.A., Van Steeg, H., and Verbeek, S.J. (1995). Increased susceptibility to ultraviolet-B and carcinogenesis of mice lacking the DNA excision repair gene Xpa. Nature 337, 169—73.
  • IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Some Pharmaceutical Drugs (1980). IARC Monographs 24, 211—41.[Medline] [Order article via Infotrieve]
  • IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Overall Evaluations of Carcinogenicity: An updating of IARC Monographs volumes 1 to 42 (1987). IARC Monographs Supplement 7, 310—2.
  • Lina, B.A.R., Bos-Kuijpers, M.H.M., Til, H.P., and Bär, A. (1996). Chronic toxicity and carcinogenicity study of erythritol in rats. Reg Toxicol Pharmacol 24, 264—79.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mortensen, A., Bertram, M., Aarup, V. and Sørensen, I. (2002). Assessment of carcinogenicity of di(2-ethylhexyl)phthalate in a short-term assay using XPA-/- and XPA-/- /p53+/- mice. Toxicol Pathol 30, 188—99.[Abstract/Free Full Text]
  • Nakanishi, K., Kurata, Y., Oshima, M., Fukushima, S., and Ito, N. (1982). Carcinogenicity of phenacetin: long-term feeding study in B6C3F1 mice. Int J Cancer 29, 439—44.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • NTP (1980). National Toxicology Program. Bioassay of reserpine for possible carcinogenicity. NCI Carcinogenesis Technical Report Series 193.
  • NTP Working group (1982). Carcinogenesis bioassay of D-mannitol in F344/N rats and B6C3F1 mice. National Toxicology Program Technical Report Series 236, 158 p.
  • Popp, J.A. (2001). Criteria for the evaluation of studies in transgenic models. Toxicol Pathol 29 (suppl) 20—3.[Abstract/Free Full Text]
  • Pritchard, J.B., French, J.E., Davis, B.J., and Haseman, J.K. (2003). The role of transgenic models in carcinogen identification. Environ Health Perspect 111, 444—54.[Web of Science][Medline] [Order article via Infotrieve]
  • Robinson, D.E. (1998). The International Life Science Institute's role in the evaluation of alternative methodologies for the assessment of carcinogenic risk. Toxicol Pathol 26, 474—5.[Free Full Text]
  • Robinson, D.E., and McDonald, J.S. (2001). Background and framework for ILSI's collaborative evaluation program on alternative models for carcinogenicity assessment. Toxicol Pathol 29 (suppl), 13—19.[Abstract/Free Full Text]
  • Storer, R.D., French, J.E., Haseman, J., Hajian, G., LeGrand, E.K., Long, G.G., Mixson, L.A., Ochoa, R., Sagartz, J.E., and Soper, K.A. (2001). p53+/- Hemizygous knockout mouse: overview of available data. Toxicol Pathol 29 (suppl), 30—50.[Abstract/Free Full Text]
  • Tennant, R.W., French, J.E., and Spalding, J.W. (1995). Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ Health Perspect 103, 942—50.[Web of Science][Medline] [Order article via Infotrieve]
  • Van Benthem, J., van den Berg, J.A.H., Beems, R.B., van Steeg, H., and van Kreijl, C.F. (2001). Concurrent positive control studies with p-cresidine and 2-AAF in wild-type, XPA-/- and XPA-/-/p53+/- mice. Toxicologic Pathology 29(suppl), 280—2.
  • Van Kreijl, C.F., McAnulty, P.A., Beems, R.B., Vynckier, A., Van Steeg, H., Fransson-Steen, R., Alden, C.L., Forster, R., Van der Laan, J.-W., and Vandenberghe, J. (2001). Xpa and Xpa/p53 knockout mice: overview of available data. Toxicol Pathol 29 (suppl), 117—28.[Abstract/Free Full Text]
  • Van Kreijl, C.F., and Van Steeg, H. (1998). Transgenic mouse models for the identification of human carcinogens: a European perspective. Toxicol Pathol 26, 757—8.[Free Full Text]
  • Van Oostrum, C. Th. M., Boeve, M., Van den Berg, J., de Vries, A., Dollé M.E.T., Beems, R.B., Van Kreijl, C.F., Vijg, J., and Van Steeg, H. (1999). The effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient Xpa mice. Environ Mol Mutagen 34, 124—30.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Van Steeg, H., de Vries, A., Van Oostrum, C. Th. M., Van Benthem, J., Beems, R.B., and Van Kreijl, C.F. (2001). DNA repair-deficientXpaandXpa/p53+/Knock-out mice: nature of the models. Toxicol Pathol 29 (suppl), 109—16.[Abstract/Free Full Text]
  • Van Steeg, H., Klein, H., Beems, R.B., and Van Kreijl, C.F. (1998). Use of DNA repair-deficient Xpa transgenic mice in short-term carcinogenicity testing. Toxicol Pathol 26, 742—9.[Abstract/Free Full Text]
  • Yamamoto, S., Mitsumorfi, K., Kodama, Y., Matsunuma, N., Manabe, S., Okamya, H., Suzuki, H., Fukada, T., Sakamaki, Y., Sunaga, M., Nomura, G., Hioki, K., Wakana, S., Nomura, T., and Hayashi, Y. (1996). Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-H-ras gene, than in control non-transgenic mice. Carcinogenesis 17, 2455—61.[Abstract/Free Full Text]

Toxicologic Pathology, Vol. 32, No. 2, 192-201 (2004)
DOI: 10.1080/01926230490274344


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lina, B. A.R.
Right arrow Articles by Van Kreijl, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lina, B. A.R.
Right arrow Articles by Van Kreijl, C. F.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*D-MANNITOL
*HALOPERIDOL
*PHENACETIN
*RESERPINE
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?